ReviewInternational journal of molecular sciences2026

PARP Inhibitor Sensitivity in Tumors Harboring Non-BRCA Homologous Recombination Gene Alterations: Current Evidence Across Ovarian, Breast, Prostate, and Pancreatic Cancers.

Elizabeth Santana Dos Santos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.